Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for JAGSONPAL PHARMACEUTICALS
Please provide your vote to see the results

JAGSONPAL PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 18.3016.1727.996.601.05

What is the latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of JAGSONPAL PHARMACEUTICALS is 18.30 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar202418.30
Mar202316.17
Mar202227.99
Mar20216.60
Mar20201.05

How is EV/Core EBITDA of JAGSONPAL PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2024 18.3
13.17
Mar2023 16.17
-42.23
Mar2022 27.99
324.09
Mar2021 6.6
528.57
Mar2020 1.05 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,574.7 Cr 2.6% 0.5% 75% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,865.0 Cr -0.5% -8.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹173,574.0 Cr -2.4% 7.2% 50.6% Stock Analytics
CIPLA ₹118,710.0 Cr -0.7% -3.7% -1% Stock Analytics
TORRENT PHARMACEUTICALS ₹105,964.0 Cr -1.4% -3.9% 19% Stock Analytics
DR REDDYS LABORATORIES ₹104,232.0 Cr 0.5% 5.6% 5.1% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

2.6%

0.5%

75%

SENSEX

-1%

1.4%

7.9%


You may also like the below Video Courses